Bone Biologics Corporation Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| UBS GROUP AG | 02/14/2025 | 21,866 | $20,554 | -33.44% | 1.25% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 15,355 | $14,438 | 100.00% | 0.88% |
| HRT FINANCIAL LP | 02/14/2025 | 14,658 | $13,000 | -34.20% | 0.84% |
| CITIGROUP INC | 02/12/2025 | 4,948 | $4,653 | 100.00% | 0.28% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 3,387 | $3,184 | 89.64% | 0.19% |
| 02/06/2025 | 1 | $1 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bone Biologics Corporation institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of Bone Biologics Corporation. The most heavily invested institutionals were:
UBS Group AG: 21,866
GEODE CAPITAL MANAGEMENT, LLC: 15,355
HRT FINANCIAL LP: 14,658
CITIGROUP INC: 4,948
Tower Research Capital LLC (TRC): 3,387
3.44% of Bone Biologics Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 60,214 shares in the last 24 months. This purchase volume represents approximately $69,246 in transactions.